• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

匹兹堡抗凝血酶:一种导致出血性疾病的α1抗胰蛋白酶变体。

Antithrombin Pittsburgh: an alpha1-antitrypsin variant causing hemorrhagic disease.

作者信息

Lewis J H, Iammarino R M, Spero J A, Hasiba U

出版信息

Blood. 1978 Jan;51(1):129-37.

PMID:412531
Abstract

A 10-year-old boy had a severe lifelong hemorrhagic disorder that had necessitated more than 50 hospitalizations. Laboratory examination showed prolonged bleeding, clotting, partial thromboplastin, prothrombin, and thrombin times. These findings were due to a potent inhibitor of the thrombin-fibrinogen reaction. This inhibitor was similar to heparin in that it acted immediately and did not interfere with the coagulant activities of certain venoms. It differed from heparin in not being adsorbed to barium citrate or neutralized by protamine sulfate. The inhibitory effect was found in the alpha1-globulin fraction. It was identified immunologically and functionally as a double-banded alpha1-antitrypsin of a previously unreported phenotype. The inhibitory effects were depressed by trypsin and heterologous anti-alpha1-antitrypsin.

摘要

一名10岁男孩患有严重的终身出血性疾病,为此他已住院50多次。实验室检查显示出血时间、凝血时间、部分凝血活酶时间、凝血酶原时间和凝血酶时间延长。这些发现是由于一种强力的凝血酶-纤维蛋白原反应抑制剂所致。这种抑制剂与肝素相似,因为它能立即起作用,且不干扰某些蛇毒的凝血活性。它与肝素的不同之处在于它不被柠檬酸钡吸附,也不被硫酸鱼精蛋白中和。抑制作用存在于α1球蛋白部分。通过免疫学和功能鉴定,它是一种以前未报道过的表型的双条带α1抗胰蛋白酶。胰蛋白酶和异源抗α1抗胰蛋白酶可降低其抑制作用。

相似文献

1
Antithrombin Pittsburgh: an alpha1-antitrypsin variant causing hemorrhagic disease.匹兹堡抗凝血酶:一种导致出血性疾病的α1抗胰蛋白酶变体。
Blood. 1978 Jan;51(1):129-37.
2
A new assay for the measurement of total progressive antithrombin.一种用于测量总活性抗凝血酶的新检测方法。
Br J Haematol. 1975 May;30(1):103-15. doi: 10.1111/j.1365-2141.1975.tb00523.x.
3
Enhancement of migration inhibitory factor activity by plasma esterase inhibitors.血浆酯酶抑制剂对迁移抑制因子活性的增强作用。
J Biol Chem. 1975 Aug 25;250(16):6608-13.
4
α -antitrypsin Pittsburgh and plasmin-mediated proteolysis.α-抗胰蛋白酶匹兹堡和纤溶酶介导的蛋白水解。
J Thromb Haemost. 2016 Oct;14(10):2023-2026. doi: 10.1111/jth.13426. Epub 2016 Sep 2.
5
Canonical inhibitor-like interactions explain reactivity of alpha1-proteinase inhibitor Pittsburgh and antithrombin with proteinases.典型的抑制剂样相互作用解释了α1-蛋白酶抑制剂匹兹堡变体和抗凝血酶与蛋白酶的反应性。
J Biol Chem. 2003 Sep 26;278(39):37881-7. doi: 10.1074/jbc.M305195200. Epub 2003 Jul 14.
6
Mutation of antitrypsin to antithrombin. alpha 1-antitrypsin Pittsburgh (358 Met leads to Arg), a fatal bleeding disorder.抗胰蛋白酶突变为抗凝血酶。α1-抗胰蛋白酶匹兹堡型(358位甲硫氨酸突变为精氨酸),一种致命的出血性疾病。
N Engl J Med. 1983 Sep 22;309(12):694-8. doi: 10.1056/NEJM198309223091203.
7
Reduction of thrombus size in murine models of thrombosis following administration of recombinant α1-proteinase inhibitor mutant proteins.α1-蛋白酶抑制剂突变蛋白给药后,在血栓形成的小鼠模型中血栓大小减少。
Thromb Haemost. 2012 May;107(5):972-84. doi: 10.1160/TH11-09-0604. Epub 2012 Feb 28.
8
Inactivation of human thrombin in the presence of human alpha1-proteinase inhibitor.在人α1-蛋白酶抑制剂存在的情况下人凝血酶的失活
Biochem J. 1976 Dec 1;159(3):495-502. doi: 10.1042/bj1590495.
9
Deletion of P1 arginine in a novel antithrombin variant (antithrombin London) abolishes inhibitory activity but enhances heparin affinity and is associated with early onset thrombosis.在一种新型抗凝血酶变体(抗凝血酶伦敦)中删除P1精氨酸会消除抑制活性,但会增强肝素亲和力,并与早发性血栓形成有关。
J Biol Chem. 2003 Apr 18;278(16):13688-95. doi: 10.1074/jbc.M300062200. Epub 2003 Feb 18.
10
Alpha 1-antitrypsin: the effect of anticoagulants on the trypsin inhibitory capacity, concentration and phenotype.α1-抗胰蛋白酶:抗凝剂对胰蛋白酶抑制能力、浓度及表型的影响
J Clin Chem Clin Biochem. 1985 May;23(5):277-81. doi: 10.1515/cclm.1985.23.5.277.

引用本文的文献

1
High-throughput amino acid-level characterization of the interactions of plasminogen activator inhibitor-1 with variably divergent proteases.纤溶酶原激活物抑制剂-1与可变差异蛋白酶相互作用的高通量氨基酸水平表征
Protein Sci. 2025 Apr;34(4):e70088. doi: 10.1002/pro.70088.
2
Anticoagulant SERPINs: Endogenous Regulators of Hemostasis and Thrombosis.抗凝血丝氨酸蛋白酶抑制剂:止血和血栓形成的内源性调节因子。
Front Cardiovasc Med. 2022 May 3;9:878199. doi: 10.3389/fcvm.2022.878199. eCollection 2022.
3
The Path to Therapeutic Furin Inhibitors: From Yeast Pheromones to SARS-CoV-2.
从酵母信息素来治疗性丝氨酸蛋白酶抑制剂:探索新型抗 SARS-CoV-2 药物。
Int J Mol Sci. 2022 Mar 22;23(7):3435. doi: 10.3390/ijms23073435.
4
Targeted SERPIN (TaSER): A dual-action antithrombotic agent that targets platelets for SERPIN delivery.靶向丝氨酸蛋白酶抑制剂(TaSER):一种双重作用的抗血栓药物,可将 SERPIN 递送至血小板。
J Thromb Haemost. 2022 Feb;20(2):353-365. doi: 10.1111/jth.15554. Epub 2021 Oct 29.
5
Blood Clotting and the Pathogenesis of Types I and II Hereditary Angioedema.血液凝固与 I 型和 II 型遗传性血管性水肿的发病机制。
Clin Rev Allergy Immunol. 2021 Jun;60(3):348-356. doi: 10.1007/s12016-021-08837-6. Epub 2021 May 6.
6
Therapeutic SERPINs: Improving on Nature.治疗性丝氨酸蛋白酶抑制剂:向自然借鉴并加以改进。
Front Cardiovasc Med. 2021 Mar 31;8:648349. doi: 10.3389/fcvm.2021.648349. eCollection 2021.
7
Leveraging Population Genomics for Individualized Correction of the Hallmarks of Alpha-1 Antitrypsin Deficiency.利用群体基因组学对α-1抗胰蛋白酶缺乏症的特征进行个体化校正。
Chronic Obstr Pulm Dis. 2020 Jul;7(3):224-246. doi: 10.15326/jcopdf.7.3.2019.0167.
8
Engineering the serpin α -antitrypsin: A diversity of goals and techniques.工程化丝氨酸蛋白酶抑制剂 α1-抗胰蛋白酶:多样化的目标和技术。
Protein Sci. 2020 Apr;29(4):856-871. doi: 10.1002/pro.3794. Epub 2019 Dec 9.
9
Serpin targets in hemostasis/kinin formation.丝氨酸蛋白酶抑制剂在止血/激肽形成中的作用靶点。
Blood. 2019 Nov 7;134(19):1566-1568. doi: 10.1182/blood.2019002713.
10
Design and characterization of α1-antitrypsin variants for treatment of contact system-driven thromboinflammation.针对接触系统驱动的血栓炎症的 α1-抗胰蛋白酶变体的设计与表征。
Blood. 2019 Nov 7;134(19):1658-1669. doi: 10.1182/blood.2019000481.